Skeletal Radiology

, Volume 34, Issue 1, pp 35–41 | Cite as

The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study

  • Giovanni La Montagna
  • Antonio Sodano
  • Vittorio Capurro
  • Domenico Malesci
  • Gabriele Valentini



To assess the clinical and radiological features of systemic sclerosis (SSc) joint involvement in a prospective cross-sectional study.

Design and patients

Seventy-six consecutive patients with SSc divided into clinical and serological subsets were investigated. Clinical and radiological assessments of the hands and feet were carried out. Three radiological patterns of inflammatory, degenerative and fibrotic changes were predefined. The Health Assessment Questionnaire (HAQ) disability index (DI) and individual components of the HAQ-DI were also evaluated.


The highest impairments on the HAQ-DI (median 0.44; range 0–2.87) were detected in subdimensions such as hygiene, grip and activity components. Clinically articular involvement, arthralgia and finger contractures were seen more frequently than arthritis, and a significantly higher prevalence of finger flexion was found in patients with diffuse cutaneous SSc (P=0.03) compared with the other SSc subtypes. Radiologically, distal interphalangeal joint space narrowing and flexion deformity indicating periarticular fibrosis were frequently detected. Juxta-articular osteoporosis, joint space narrowing and flexion contractures of the fingers were seen significantly more frequently in the hands. A significantly higher frequency of fibrotic pattern were found in the hands whereas a degenerative pattern was more frequent in the feet (P<0.05). Finally, significant correlations were detected between flexion contractures and a radiological fibrotic pattern (P<0.001), and the severity scores of peripheral vascular impairment (P=0.026) and skin (P=0.007).


This cross-sectional prospective study confirms that an arthropathy is common in SSc patients and shows that it is a major determinant of disability. A classification of radiological alterations into three specific patterns is proposed.


Systemic sclerosis Arthropathy HAQ-DI Clinical subsets Serological subsets Radiological patterns 


  1. 1.
    Medsger TA Jr. Systemic sclerosis (scleroderma): clinical aspects. In: Koopman WJ, ed. Arthritis and allied conditions, 14th edn. Philadelphia: Lippincott Williams & and Wilkins, 2001:1590–1624.Google Scholar
  2. 2.
    Blocka K. Organ involvement: musculoskeletal. In: Clements PJ, Furst D, eds. Systemic sclerosis. Philadelphia: Williams & Wilkins, 1996:411–424.Google Scholar
  3. 3.
    Seibold JR. Scleroderma and mixed connective tissue diseases. In: Ruddy S, Harris ED, Sledge CB, eds. Kelley’s textbook of rheumatology, 6th edn. Philadelphia: WB Saunders, 2001:1211–1239.Google Scholar
  4. 4.
    Zimmerman C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 1998; 41:1938–1945.Google Scholar
  5. 5.
    La Montagna G, Baruffo A, Tirri R, Buono G, Valentini G. Foot involvement in systemic sclerosis. Semin Arthritis Rheum 2002; 31:248–255.CrossRefPubMedGoogle Scholar
  6. 6.
    Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic And Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581–590.PubMedGoogle Scholar
  7. 7.
    Giordano M, Valentini G, Migliaresi S, Picillo U, Vatti M. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis. J Rheumatol 1986; 13:911–916.PubMedGoogle Scholar
  8. 8.
    Ferri C, Valentini G, Cozzi F, et al. Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serological features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81:139–153.Google Scholar
  9. 9.
    Scussel-Lonzetti L, Joyal F, Raynauld JP, et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2003; 81:154–167.Google Scholar
  10. 10.
    Akesson A, Fior G, Krieg T, van Den Hoogen FHJ, Seibold JR. Assessment of skin, joint, tendon muscle involvement. Clin Exp Rheumatol 2003; 21 (Suppl 29):S5―S8.Google Scholar
  11. 11.
    Kahaleh B, Meyer O, Scorza R. Assessment of vascular involvement. Clin Exp Rheumatol 2003; 21(Suppl 29):S9―S14.Google Scholar
  12. 12.
    Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003; 21(Suppl 29):S15―S18.Google Scholar
  13. 13.
    Matucci Cerinic M, D’Angelo S, Denton C, Vlachoyiannopoulos P, Silver R. Assessment of lung involvement. Clin Exp Rheumatol 2003; 21 (Suppl 29):S19―S23.Google Scholar
  14. 14.
    Ferri C, Emdin M, Nielsen H, Bruhlmann P. Assessment of heart involvement: Clin Exp Rheumatol 2003; 21(Suppl 29):S24―S28.Google Scholar
  15. 15.
    Steen VD, Mayes MD, Merkel PA. Assessment of kidney involvement. Clin Exp Rheumatol 2003; 21(Suppl 29):S29―S31.Google Scholar
  16. 16.
    McHugh NJ, Distler O, Giacomelli R, Riemekasten G. Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 2003; 21(Suppl 29):S32―S38.Google Scholar
  17. 17.
    Valentini G, Silman AJ, Veale D. Assessment of disease activity. Clin Exp Rheumatol 2003; 21(Suppl 29):S39―S41.Google Scholar
  18. 18.
    Medsger TA Jr, Bombardieri S, Czirijak I, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21(Suppl 29):S42―S46.Google Scholar
  19. 19.
    Valentini G, Medsger TA Jr, Silman AJ, Bombardieri S. Conclusion and identification of the core set of variables to be used in clinical investigations. Clin Exp Rheumatol 2003; 21 (Suppl 29):S47–S48.Google Scholar
  20. 20.
    Clements PJ, Wong WK, Hurwitz EL, et al. Correlates of the disability index of the health assessment questionnaire. A measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999; 42:2372–2380.CrossRefPubMedGoogle Scholar
  21. 21.
    Ranza R, Marchesoni A, Calori G, et al. The Italian version of the functional disability index of the health assessment questionnaire. A reliable instrument for multicenter study on rheumatoid arthritis. Clin Exp Rheumatol 1993; 11:123–128.Google Scholar
  22. 22.
    Fries JF, Spitz P, Kraines G, Holman HR. Measurement of patients outcome in arthritis. Arthritis Rheum 1980; 23:137–145.PubMedGoogle Scholar
  23. 23.
    Baron M, Srolovitz H, Lander P, Kapusta M. The coexistence of rheumatoid arthritis and scleroderma: a case report and review of the literature. J Rheumatol 1982; 9:947–950.PubMedGoogle Scholar
  24. 24.
    Misra R, Darton K, Jewkes RF, Black CM, Maini RN. Arthritis in scleroderma. Br J Rheumatol 1995; 34:831–837.Google Scholar
  25. 25.
    Horiki T, Moriuchi J, Takaya M, et al. The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity. Arthritis Rheum 1996; 39:152–156.PubMedGoogle Scholar
  26. 26.
    Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis. Clin Exp Rheumatol 2003; 21:91–94.Google Scholar
  27. 27.
    Lovell CR, Jayson MIV. Joint involvement in systemic sclerosis. Scand J Rheumatol 1979; 8:154–160.PubMedGoogle Scholar
  28. 28.
    Bloka KLN, Bassett LW, Furst DE, Clements PJ, Paulus H. The arthropathy of advanced progressive systemic sclerosis. A radiographic survey. Arthritis Rheum 1981; 234:874–884.Google Scholar
  29. 29.
    Armstrong RD, Gibson T. Scleroderma and erosive polyarthritis: a disease entity ? Ann Rheum Dis 1982; 41:141–146.Google Scholar
  30. 30.
    Gladman DD, Rahman P. Psoriatic arthritis. In: Ruddy S, Harris ED, Sledge CB, eds. Kelley’s textbook of rheumatology, 6th edn. Philadelphia: WB Saunders, 2001:1071–1079.Google Scholar
  31. 31.
    Fischer F. Development of erosions in the finger phalanges during absorption of periosseous calcification. ROFO Fortschr Geb Rontgenstr Nuklearmed 1984; 141:87–91.PubMedGoogle Scholar
  32. 32.
    Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315–324.PubMedGoogle Scholar
  33. 33.
    Rodnan GP. The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma). Ann Intern Med 1962; 56:422–429.PubMedGoogle Scholar
  34. 34.
    Clarke MD, Winkelman RK, McDuffe FC, Ward CE. Synovial tissue changes and rheumatoid factor in scleroderma. Mayo Clin Proc 1971; 46:97–101.PubMedGoogle Scholar
  35. 35.
    Peterfy CG. MR imaging. In: Bird HA, Dougados M, eds. Imaging techniques. Part II: Modern methods. Baillieres Clin Rheumatol 1996; 10:645–678.Google Scholar

Copyright information

© ISS 2004

Authors and Affiliations

  • Giovanni La Montagna
    • 1
  • Antonio Sodano
    • 2
  • Vittorio Capurro
    • 2
  • Domenico Malesci
    • 1
  • Gabriele Valentini
    • 1
  1. 1.Dipartimento Medico-Chirurgico di Internistica, Clinica e Sperimentale “F Magrassi e A Lanzara”, Unità Operativa di ReumatologiaSeconda Università di NapoliNaplesItaly
  2. 2.Dipartimento di Diagnostica per Immagini e RadioterapiaUniversità “Federico II”NaplesItaly

Personalised recommendations